Pinz Capital Management’s MacroGenics MGNX Stock Holding History

Pinz Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,900	Closed	-$156K	–	495
2021 Q1	$156K	Buy	+4,900	New	+$119K	0.04%	119

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Pinz Capital Management's MGNX Position: Q2 2021 in Review

Pinz Capital Management sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 4,900 shares — an estimated $156K sold.

Pinz Capital Management first reported a position in MGNX in Q1 2021 and held it in 1 quarter. The position peaked at $156K in Q1 2021. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

Pinz Capital Management reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
Pinz Capital Management sold 4,900 MacroGenics shares in Q2 2021, an estimated $156K.
Pinz Capital Management first reported a position in MacroGenics in Q1 2021 and held it in 1 quarter.
Pinz Capital Management's MacroGenics position peaked at $156K in Q1 2021.
149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Pinz Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.